AI and Healthcare

Why Most AI Startups in Healthcare Fail

What separates scalable healthcare AI from hype? Dr. Bernardo Perez-Villa, Cleveland Clinic's Senior Innovations Engagement Partner, breaks down how to validate AI ideas, assess product-market fit, and build business models that survive reimbursement hurdles. Hosted by Dr. Sanjay Juneja.

Cancer Detection MRI Imaging vs Blood Tests

Why rely on one method when three are better? Ezra CEO Emi Gal explains how combining imaging, liquid biopsy, and biomarkers creates a superior cancer screening protocol. He also shares how AI enables longitudinal tracking of lesions, reducing false positives and patient anxiety. Learn what makes Ezra’s approach uniquely effective in the fight against cancer.

How AI Makes Full-Body MRI Faster and Cheaper

Discover how Ezra uses FDA-cleared AI to transform MRI imaging. CEO Emi Gal explains how Ezra Flash speeds up scan times while improving quality, and how Ezra Assist aids radiologists with accurate annotations. Their AI-powered process makes full-body cancer screening possible in just 22 minutes—for under $500. Learn how this innovation is redefining medical imaging from acquisition to interpretation.

Should Patients Be Paid for Sharing Health Data?

Can patients and clinicians be fairly rewarded for sharing healthcare data? Rajeev Ronanki, CEO of Lyric, discusses a future where AI-enabled tools empower community oncology practices with personalized digital agents. He outlines how reimbursement models can support physicians scaling their care using AI, and why rewarding patient data sharing is both ethical and economically sound.

AI Makes Full Body MRI Screening Affordable - with Emi Gal

Ezra CEO Emi Gal breaks down how AI is revolutionizing full-body MRI cancer screening. Learn how FDA-cleared tools accelerate scan time, assist radiologists, and empower patients with easy-to-understand reports—all for just $499. Discover why early detection matters, especially for younger adults, and how Ezra is scaling access to lifesaving diagnostics.

Inside the FDA’s Bold Elsa AI Move: Rajeev Ronanki Explains

Rajeev Ronanki, CEO of Lyric and former Elevance Health executive, unpacks what the FDA’s AI initiative—Elsa—really means for drug innovation and regulation. Rajeev outlines how the agency can use data it already has to drive smarter, faster decisions. He draws powerful parallels to autonomous vehicles and urges the FDA to embrace AI while maintaining scientific rigor.

Trust, ethics, and data bias in AI

Trust in AI cannot exist without ethics - and ethics cannot exist without confronting data bias. Discover how artificial intelligence can become a force for safety, fairness, and innovation in healthcare when designed with integrity from the ground up.

In this compelling exchange, Dr. Sanjay Juneja (sjunejamd.com) interviews Rajeev Ronanki (LinkedIn), CEO of Lyric, to uncover how AI can be engineered to identify bias, self-evaluate decisions, and evolve into a trusted collaborator in clinical care. They reveal practical strategies for bias detection, the vision of an "AI Hippocratic Oath," and why ethics must precede deployment - especially in medicine.

Healthcare leaders, CIOs, CMOs, engineers, and innovators will gain critical insight into governance frameworks that future-proof AI adoption.

Rajeev Ronanki: Real-Time Payer-Provider Collaboration

Rajeev Ronanki, CEO of Lyric and author of You and AI, joins Dr. Sanjay Juneja to discuss a radical rethinking of payment in healthcare. Instead of upgrading legacy systems, Rajeev proposes bypassing them using trusted AI agents that mediate between EMRs and payers. They explore real-time adjudication, the importance of trust and transparency, and how scalable AI tools can serve even community clinics. Learn how AI is reshaping healthcare finance from the ground up.